Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Lydia E. Pinkham’s Vegetable Compound was one of thousands of popular and lucrative patent medicines—health concoctions dreamed up by chemists, housewives, and entrepreneurs—that took the ...

President Donald Trump’s health secretary nominee last week indicated he’d consider authorizing the government to seize the patents of high-priced medicines from manufacturers and share them ...

In recent months China’s progress in artificial intelligence has stunned the world. A quieter yet equally significant shift ...

SHANGHAI, Feb 9 (Reuters) - China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through the country's public hospitals ...

GLEN ALLEN, Va. - Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), a biopharmaceutical company specializing in addiction treatment with a current market capitalization of $5 million, has been granted a new ...

Clearmind Medicine Inc., a Vancouver-based biotech company specializing in psychedelic-derived therapeutics, announced the publication of a new patent by Mexico's National Patent Office.

Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States ...

The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...

Robert F. Kennedy Jr. expressed openness to adopting a key progressive proposal for lowering drug prices during a closed-door meeting with Senate Finance Committee staffers, according to three ...